Pomalyst
E1584913
UNEXPLORED
Pomalyst is a prescription immunomodulatory drug (pomalidomide) primarily used to treat multiple myeloma in patients who have received prior therapies.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Pomalyst canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T23417455 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Pomalyst Context triple: [Bristol Myers Squibb, product, Pomalyst]
-
A.
Kalydeco
Kalydeco is a prescription medication used to treat certain forms of cystic fibrosis by improving the function of defective CFTR proteins.
-
B.
Gilenya
Gilenya is an oral prescription medication used to treat relapsing forms of multiple sclerosis by modulating sphingosine-1-phosphate receptors to reduce immune attacks on the nervous system.
-
C.
Anpezan
Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
-
D.
Andexxa
Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
-
E.
Talycopa
Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Pomalyst Target entity description: Pomalyst is a prescription immunomodulatory drug (pomalidomide) primarily used to treat multiple myeloma in patients who have received prior therapies.
-
A.
Kalydeco
Kalydeco is a prescription medication used to treat certain forms of cystic fibrosis by improving the function of defective CFTR proteins.
-
B.
Gilenya
Gilenya is an oral prescription medication used to treat relapsing forms of multiple sclerosis by modulating sphingosine-1-phosphate receptors to reduce immune attacks on the nervous system.
-
C.
Anpezan
Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
-
D.
Andexxa
Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
-
E.
Talycopa
Talycopa is a locality or area within the community of Llansamlet in Swansea, Wales.
- F. None of above. chosen
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.